SCD, MCI, Early Dementia and AD

Delphi-MD enables the early diagnosis of Dementia . Fogel et al; Dementia and Neurodegeneration.

Read More →



Delphi-MD detects white matter changes. Levy-Lamdan et al; Frontiers in Aging Neuroscience.


Read More →


Parkinson’s Disease

Delphi-MD in the diagnosis of PD. Meidan et al; Parkinsonism related dis.


Read More →


Delphi and Aging

Delphi-MD Diagnosis of Abnormal Aging . Zifman et al; Frontiers in Aging Neuroscience.


Read More →


White Matter Pathologies

Delphi-MD In the Detection Of Neurological Conditions And White Matter Pathologies.


Read More →




Bridging the Gap: Science Advancement and the Medical Need with Iftach Dolev, PhD – Given at The Centers for Brain Health, at The University of Texas at Dallas

Israel Healthcare Tech Ecosystem for South Korea- IEI Online Webinar.
Direct Electrophysiology Technology- How Does It Work?
Introducing The Delphi-MD Device

White Papers

Review of Neurodiagnostic Technologies

As the world’s population ages, the prevalence of neurological disorders and the need for preserving brain health are on the rise.


Read More →


GPs Are the Gatekeepers of Brain Health

Reshaping the Approach to Brain Diseases by Enhancing the Early Diagnosis Capacity of GPs.


Read More →


Pioneering Brain Health Proactive Brain Care

Why Comprehensive Testing is Vital After 50.


Read More →


Blog Articles

Press Coverage

Amyotrophic Lateral Sclerosis Pipeline Booms as 100+ Therapies Likely to Enter in the Treatment Domain | DelveInsight

The prevalence of amyotrophic lateral sclerosis has been rising over the past few years, which prompts the growing demand for treatment options. The increasing prevalence of amyotrophic lateral sclerosis and the growing research and development activities to develop novel therapies to treat amyotrophic lateral sclerosis to drive the market. The companies developing the potential therapies in the last stage of development include Biogen, AB Sciences, Helixmith, and several others.

Read original source

Brain Health Made Accessible

QuantalX’s team of neuroscientists developed a way to advance brain imaging and deliver neurological capabilities at the point of care, to enable real-time brain health measurements and promote early detection of abnormalities,
The field of neurological care struggles with low efficiency attributed to delayed detection rates and frequent misdiagnosis. Neurological conditions are often detected and diagnosed only in their advanced stages, due to prevalent practices and ineffective tools, which include subjective cognitive testing, clinical impressions, and brain imaging like CT/MRI, that do not evaluate brain function…

Read original source

Want to Join the Brain Health Revolution?

Skip to content